Tag: Hub for Advanced Manufacture of Targeted Radiopharmaceuticals
Starpharma launches R&D partnership with UQ to advance DEP cancer treatment products
Biopharmaceutical company Starpharma Holdings has ventured into a partnership with the University of Queensland’s (UQ) Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR Hub) to advance research and development on the ASX company’s targeted DEP radiotheranostic products.
Featured Article
Balancing profit and sustainability in supply chains
Priorities in the supply chain are expanding, moving away from cost as the main driver behind purchasing decisions. Now, sustainability and ethical sourcing are grabbing a portion of the spotlight.
